Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
|
|
Hoth Therapeutics, Inc. (HOTH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 10% stake in Hoth Therapeutics, Inc. |
| 03/18/2021 |
SC 13G
| Iroquois Capital Management, LLC reports a 5.5% stake in Hoth Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/25/2021 |
SC 13G
| Lind Global Macro Fund LP reports a 8.9% stake in Hoth Therapeutics, Inc. |
| 01/13/2021 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 7.6% stake in Hoth Therapeutics, Inc. |
| 01/12/2021 |
SC 13G
| Ionic Ventures, LLC reports a 9.2% stake in Hoth Therapeutics, Inc. |
| 07/21/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/04/2020 |
SC 13G
| EITNER MATTHEW D. reports a 7.8% stake in HOTH THERAPEUTICS, INC. |
| 02/28/2020 |
SC 13G
| SPHERIX INC reports a 16.2% stake in Hoth Therapeutics, Inc. |
|
|